# Vapotherm

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vapotherm

- Industry: Medical Devices & Equipment
- Headquarters: Exeter, US
- Website: www.vapotherm.com
- Total disclosed funding: $85M
- Latest round: Series D (May 11, 2017)
- Investors on record: 14

## About

Vapotherm, Inc. is a company specializing in non-invasive respiratory support solutions using high velocity therapy (HVT) to treat patients with respiratory distress across various demographics.Founded in 1999 and headquartered in Exeter, US, Vapotherm, Inc. develops innovative respiratory care solutions. The company has undergone significant growth, raising a total of USD 23.00 mn through multiple funding rounds, with the latest being a PIPE of USD 23.00 mn in November 2018. João Cunha serves as the CEO of the firm.Vapotherm specializes in high velocity therapy (HVT), a non-invasive respiratory support solution designed to treat patients experiencing respiratory distress. The company's flagship product, the HVT® 2.0 System, delivers mask-free respiratory support for a diverse patient population, including individuals with chronic obstructive pulmonary disease (COPD). The technology utilizes heated and humidified high-flow nasal cannula systems, ensuring enhanced comfort and compliance for patients intolerant of mask-based therapies. Vapotherm's products are widely distributed in over 40 countries, serving hospitals and healthcare facilities across North America, Europe, and Asia-Pacific.In 2023, Vapotherm reported a revenue of USD 68.67 mn, with an EBITDA of USD -34.10 mn. The company generates income primarily from the sales of its high velocity therapy devices and related disposable accessories to healthcare providers.Vapotherm has plans to enhance its product offerings with new innovations in respiratory technology aimed for release in the near term. The firm is also targeting expansion into additional markets, focusing on regions in Asia-Pacific by 2025. The proceeds from their latest funding round, which amounted to USD 23.00 mn, will support these initiatives and enhance their operational capacities to scale their market presence effectively.

## Funding rounds

- Series D, May 11, 2017, $20M — Morgenthaler Ventures, Gilde Healthcare, Arnerich Massena, Kaiser Permanente Ventures, Redmile Group, Perceptive Advisors
- Series C, Mar 13, 2015, $20M — Morgenthaler Ventures, Gilde Healthcare, Questmark Management Company, Adage Capital Management, Cross Creek, Kaiser Permanente Ventures, 503 Partners, Crestline Investors
- Series F, Aug 12, 2008, $21M — Questmark Management Company, Integral Capital Partners, State Street Global Advisors, Cross Creek, Kaiser Permanente Ventures
- Series E, Oct 5, 2007, $11M — Questmark Management Company, Kaiser Permanente Ventures
- Series D, Sep 1, 2006, $1.3M — Maryland Department of Business and Economic Development, Kaiser Permanente Ventures
- Series D, Jan 12, 2006, $6.7M — Questmark Management Company
- Series C, Jul 25, 2003, $5.3M — Questmark Management Company, Maryland Department of Business and Economic Development

## Investors

- Questmark Management Company (https://capitalatlas.ai/funds/questmark-management-company) — Series C, Series D, Series E, Series F
- Maryland Department of Business and Economic Development — Series C, Series D
- Kaiser Permanente Ventures (https://capitalatlas.ai/funds/kaiser-permanente-ventures) — Series D, Series E, Series F, Series C
- Integral Capital Partners (https://capitalatlas.ai/funds/integral-capital-partners) — Series F
- State Street Global Advisors — Series F
- Cross Creek (https://capitalatlas.ai/funds/cross-creek) — Series F, Series C
- Morgenthaler Ventures (https://capitalatlas.ai/funds/morgenthaler-ventures) — Series C, Series D
- Gilde Healthcare (https://capitalatlas.ai/funds/gilde-healthcare) — Series C, Series D
- Adage Capital Management — Series C
- 503 Partners (https://capitalatlas.ai/funds/503-partners) — Series C
- Crestline Investors (https://capitalatlas.ai/funds/crestline-investors) — Series C
- Arnerich Massena — Series D
- Redmile Group (https://capitalatlas.ai/funds/redmile-group) — Series D
- Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series D